Table 2.

Pro-inflammatory cytokines, mood, and sleep at pretreatment and posttreatment for CBTI-BP and PE.

	CBTI-BP				PE

	Pretreatment (n=11)		Posttreatment (n=8)		Pretreatment (n=11)		Posttreatment (n=9)
	M or N	% or SD	M or N	% or SD	M or N	% or SD	M or N	% or SD	t	p
Cytokines
IL-6^a (pg/ml)	0.85	0.73	0.69	0.46	0.77	1.27	2.48	5.25	−1.46	.16
IL-6^b (pg/ml)	−0.58	1.03	−0.59	0.75	−0.81	0.89	−0.24	1.37	−1.61	.13
sTNF-R2^a (pg/ml)	67.40	70.66	60.97	53.12	42.99	38.02	55.57	45.36	−0.81	.43
sTNF-R2^b (pg/ml)	3.72	1.04	3.79	0.87	3.54	0.65	3.82	0.62	−0.79	.44
Mood
YMRS	3.14	2.72	3.50	3.38	3.38	3.95	4.50	3.46	0.53	.60
YMRS^c	3.39	2.41	3.25	2.96	3.14	2.84	4.00	3.15	−0.01	.99
QIDS	9.91	6.39	8.25	7.21	9.50	4.58	5.67	3.39	0.59	.56
QIDS^c	7.09	6.32	6.25	6.43	7.18	4.49	3.67	3.46	0.82	.42
Sleep
Time in Bed	503.93	86.51	480.89	78.51	574.82	86.47	588.57	127.04	−1.31	.21
Total Sleep Time	396.01	82.86	409.14	100.72	441.53	87.33	491.01	94.96	−1.04	.31
Total Wake Time	104.97	34.89	73.06	28.63	135.94	41.51	97.56	73.10	0.18	.86
Sleep Onset Latency	36.85	21.22	23.82	9.88	54.25	38.11	54.46	86.25	−0.75	.46
Wake After Sleep Onset	26.98	18.48	29.18	25.87	19.45	9.24	6.83	7.03	1.49	.16
Early Morning Awakening	28.98	34.13	22.46	20.92	25.55	25.42	17.68	37.25	−0.19	.86
Sleep Efficiency	79.71	6.64	83.60	8.35	75.89	7.18	84.13	8.32	−0.93	.37

Note.

Log transformed.

Unadjusted.

Sleep items removed. The t statistic and p value refer to the interaction between condition (CBTI-BP and PE) and time (pretreatment and posttreatment).